KLP Kapitalforvaltning AS Boosts Stock Holdings in HCA Healthcare, Inc. $HCA

KLP Kapitalforvaltning AS boosted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.1% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 67,138 shares of the company’s stock after purchasing an additional 100 shares during the period. KLP Kapitalforvaltning AS’s holdings in HCA Healthcare were worth $25,721,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the stock. ORG Partners LLC raised its stake in HCA Healthcare by 27.9% during the second quarter. ORG Partners LLC now owns 142 shares of the company’s stock worth $55,000 after purchasing an additional 31 shares during the period. Avantax Advisory Services Inc. increased its position in shares of HCA Healthcare by 0.4% in the first quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company’s stock worth $2,791,000 after acquiring an additional 32 shares in the last quarter. Glenview Trust co increased its position in shares of HCA Healthcare by 2.3% in the first quarter. Glenview Trust co now owns 1,451 shares of the company’s stock worth $501,000 after acquiring an additional 32 shares in the last quarter. Horizon Investments LLC increased its position in shares of HCA Healthcare by 1.1% in the first quarter. Horizon Investments LLC now owns 3,175 shares of the company’s stock worth $1,097,000 after acquiring an additional 33 shares in the last quarter. Finally, Sivia Capital Partners LLC increased its position in shares of HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after acquiring an additional 33 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on HCA. Royal Bank Of Canada lowered their price target on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating for the company in a report on Monday, July 28th. Wolfe Research lowered shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. Weiss Ratings reissued a “buy (b-)” rating on shares of HCA Healthcare in a report on Saturday, September 27th. Bank of America raised their price objective on shares of HCA Healthcare from $375.00 to $410.00 and gave the stock a “neutral” rating in a report on Wednesday, September 10th. Finally, Wall Street Zen upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, July 5th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $410.83.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $437.46 on Wednesday. The company has a market cap of $102.36 billion, a P/E ratio of 18.39, a PEG ratio of 1.36 and a beta of 1.40. The firm’s 50-day moving average is $401.26 and its 200-day moving average is $374.10. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $439.01.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating the consensus estimate of $6.20 by $0.64. The firm had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. HCA Healthcare’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period last year, the firm posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were given a $0.72 dividend. The ex-dividend date was Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.11%.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is currently owned by corporate insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.